PetMed Express Files Proxy Statement Amendment

TL;DR

PETS filed an amendment to its proxy statement for the 2024 annual meeting. Shareholders get more info.

AI Summary

PetMed Express, Inc. (PETS) filed an amendment to its definitive proxy statement for the 2024 Annual Meeting. This filing, dated July 2, 2024, is an amendment to the Schedule 14A information and concerns the company's proxy statement.

Why It Matters

This filing provides shareholders with updated information regarding the company's upcoming annual meeting, which is crucial for their voting decisions on corporate matters.

Risk Assessment

Risk Level: low — This is a routine administrative filing related to a proxy statement, not indicating any immediate financial or operational risks.

Key Players & Entities

• PETMED EXPRESS, INC. (company) — Registrant
• 0001040130-24-000058 (filing_id) — Accession Number
• 20240702 (date) — Filing Date

FAQ

Key Financial Figures

• $100 — to Other NEOs 2 Value of Initial Fixed $100 Investment Based On Net Income ($Mn)
• $0 — R Peer Group Cumulative TSR 3 2024 $0 $534,019 $0 -$70,181 $635,255 $358,968
• $534,019 — Peer Group Cumulative TSR 3 2024 $0 $534,019 $0 -$70,181 $635,255 $358,968 $19.90 $5
• $70,181 — umulative TSR 3 2024 $0 $534,019 $0 -$70,181 $635,255 $358,968 $19.90 $511.93 -$7.46
• $635,255 — e TSR 3 2024 $0 $534,019 $0 -$70,181 $635,255 $358,968 $19.90 $511.93 -$7.46 $4.79 2
• $358,968 — 2024 $0 $534,019 $0 -$70,181 $635,255 $358,968 $19.90 $511.93 -$7.46 $4.79 2023 $0 $5
• $19.90 — $534,019 $0 -$70,181 $635,255 $358,968 $19.90 $511.93 -$7.46 $4.79 2023 $0 $534,119
• $511.93 — 19 $0 -$70,181 $635,255 $358,968 $19.90 $511.93 -$7.46 $4.79 2023 $0 $534,119 $0 -$7,4
• $7.46 — 0,181 $635,255 $358,968 $19.90 $511.93 -$7.46 $4.79 2023 $0 $534,119 $0 -$7,454,281
• $4.79 — $635,255 $358,968 $19.90 $511.93 -$7.46 $4.79 2023 $0 $534,119 $0 -$7,454,281 $616,1
• $534,119 — 68 $19.90 $511.93 -$7.46 $4.79 2023 $0 $534,119 $0 -$7,454,281 $616,191 $389,848 $64.67
• $7,454,281 — 1.93 -$7.46 $4.79 2023 $0 $534,119 $0 -$7,454,281 $616,191 $389,848 $64.67 $393.15 $5.14
• $616,191 — $4.79 2023 $0 $534,119 $0 -$7,454,281 $616,191 $389,848 $64.67 $393.15 $5.14 $16.24 2
• $389,848 — 023 $0 $534,119 $0 -$7,454,281 $616,191 $389,848 $64.67 $393.15 $5.14 $16.24 2022 $1,23
• $64.67 — 34,119 $0 -$7,454,281 $616,191 $389,848 $64.67 $393.15 $5.14 $16.24 2022 $1,237,110 $

Filing Documents

• amno1to2024proxystatemente.htm (DEFA14A) — 29KB
• 0001040130-24-000058.txt ( ) — 30KB

From the Filing

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 PETMED EXPRESS, INC. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply) No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. EXPLANATORY NOTE This Amendment No. 1 to Schedule 14A (the "Amendment") is being filed to amend PetMed Express, Inc.'s (the "Company") definitive proxy statement for its 2024 Annual Meeting of Shareholders (the "Proxy Statement"), which was filed with the Securities and Exchange Commission on June 24, 2024. The Amendment amends the disclosure in the Proxy Statement under the section "Executive Compensation," subsection "2024 Pay versus Performance Disclosure," to correct certain information in the "Pay versus Performance Table" regarding information for the Other NEOs,' for the fiscal years 2022 and 2021. No other changes have been made to the Proxy Statement or to the matters to be considered by the shareholders. All other items of the Proxy Statement are incorporated herein by reference without change. Capitalized terms used but not otherwise defined in this Amendment shall have the meanings assigned to such terms in the Proxy Statement. This Amendment should be read in conjunction with the Proxy Statement. AMENDMENT TO PROXY STATEMENT In connection with the "Pay versus Performance Table," the table, set forth on page 52 of the Proxy Statement, is amended and restated as follows Pay versus Performance Table Year 1 Summary Compensation Table Total for CEO (Akdag) Summary Compensation Table Total for CEO (Hulett) Compensation Actually Paid to CEO (Akdag) Compensation Actually Paid to CEO (Hulett) 2 Average Summary Compensation Table Total for Other NEOs Average Compensation Actually Paid to Other NEOs 2 Value of Initial Fixed $100 Investment Based On Net Income ($Mn) Company Selected Performance Measure Stock Price 4 Company Cumulative TSR Peer Group Cumulative TSR 3 2024 $0 $534,019 $0 -$70,181 $635,255 $358,968 $19.90 $511.93 -$7.46 $4.79 2023 $0 $534,119 $0 -$7,454,281 $616,191 $389,848 $64.67 $393.15 $5.14 $16.24 2022 $1,237,110 $12,602,605 $1,094,037 $10,031,005 $956,459 $722,151 $96.82 $404.58 $18.72 $25.80 2021 $2,194,586 $0 $2,429,241 $0 $784,689 $909,443 $126.46 $497.53 $23.92 $35.18

View Full Filing

View this DEFA14A filing on SEC EDGAR